Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Fainareti N Zervou"'
Autor:
Ioannis M Zacharioudakis, Fainareti N Zervou, Prithiv J Prasad, Yongzhao Shao, Atreyee Basu, Kenneth Inglima, Scott A Weisenberg, Maria E Aguero-Rosenfeld
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who ha
Externí odkaz:
https://doaj.org/article/04698c6ff4ec47ebb0b036a93566c566
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217508 (2019)
ObjectivesSepsis presents a major burden to the emergency department (ED). Because empiric inappropriate antimicrobial therapy (IAAT) is associated with increased mortality, rapid molecular assays may decrease IAAT and improve outcomes. We evaluated
Externí odkaz:
https://doaj.org/article/c7866ee1cd914843b00a12dd34058b72
Autor:
Christos A Grigoras, Fainareti N Zervou, Ioannis M Zacharioudakis, Constantinos I Siettos, Eleftherios Mylonakis
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156577 (2016)
Clostridium difficile infection is the most common hospital-acquired infection. Besides infected patients, carriers have emerged as a key player in C. difficile epidemiology. In this study, we evaluated the impact of identifying and isolating carrier
Externí odkaz:
https://doaj.org/article/a57ca2c888784d308f1e2381df261d23
Autor:
Suresh Paudel, Ioannis M Zacharioudakis, Fainareti N Zervou, Panayiotis D Ziakas, Eleftherios Mylonakis
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124483 (2015)
Several factors including antibiotic use, immunosuppression and frequent hospitalizations make solid organ transplant (SOT) recipients vulnerable to Clostridium difficile infection (CDI). We conducted a meta-analysis of published studies from 1991-20
Externí odkaz:
https://doaj.org/article/ee1b3170f00b4be3a349d666d0389642
Autor:
Panayiotis D Ziakas, Ioannis M Zacharioudakis, Fainareti N Zervou, Christos Grigoras, Elina Eleftheria Pliakos, Eleftherios Mylonakis
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117195 (2015)
BackgroundThe impact of Clostridium difficile colonization in C. difficile infection (CDI) is inadequately explored. As a result, asymptomatic carriage is not considered in the development of infection control policies and the burden of carrier state
Externí odkaz:
https://doaj.org/article/dbabe3dfd632433da5b360c1e20ef608
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114735 (2014)
Graft-versus-host Disease (GvHD) prophylaxis after allogeneic hematopoietic stem-cell transplantation (HSCT) is an ongoing effort but relative effects of different policies are not systematically explored.We systematically reviewed 30-year evidence o
Externí odkaz:
https://doaj.org/article/8c575a2f27bb4061ac6a331fad4d6c2d
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Mycoplasma hominis is a facultative anaerobic bacterium commonly present in the urogenital tract. In recent years, M. hominis has increasingly been associated with extra-urogenital tract infections, particularly in immunosuppresse
Externí odkaz:
https://doaj.org/article/80944ead8f6c4fc4a5e5d67dd60ead28
Publikováno v:
Future Microbiology. 17:813-817
Autor:
Ioannis M. Zacharioudakis, Maria E. Aguero-Rosenfeld, Yanina Dubrovskaya, Benjamin See, Fainareti N. Zervou, Kenneth Inglima
Publikováno v:
International Journal of Infectious Diseases, Vol 104, Iss, Pp 354-360 (2021)
Objectives: We evaluated the value of BioFire® FilmArray® pneumonia panel in establishing a microbiological diagnosis of pneumonia. We evaluated opportunities for antimicrobial optimization from its use. Methods: We included adult patients with pne
Publikováno v:
Infection Control & Hospital Epidemiology. 41:908-913
Objective:The data regarding the effectiveness of chemical prophylaxis against recurrentC. difficileinfection (CDI) remain conflicting.Design:Retrospective cohort study on the effectiveness of oral vancomycin for prevention of recurrent CDI.Setting:T